Bates GP - Search Results

1

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients.

Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RLM, Tabrizi SJ, Bates GP. Neueder A, et al. Among authors: bates gp. Sci Rep. 2017 May 2;7(1):1307. doi: 10.1038/s41598-017-01510-z. Sci Rep. 2017. PMID: 28465506 Free PMC article.

2

The Huntington's disease candidate region exhibits many different haplotypes.

MacDonald ME, Novelletto A, Lin C, Tagle D, Barnes G, Bates G, Taylor S, Allitto B, Altherr M, Myers R, et al. MacDonald ME, et al. Nat Genet. 1992 May;1(2):99-103. doi: 10.1038/ng0592-99. Nat Genet. 1992. PMID: 1302016 Review.

3

Transgenic models of Huntington's disease.

Bates GP, Mangiarini L, Mahal A, Davies SW. Bates GP, et al. Hum Mol Genet. 1997;6(10):1633-7. doi: 10.1093/hmg/6.10.1633. Hum Mol Genet. 1997. PMID: 9300654 Review.

4

Transgenic models of Huntington's disease.

Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P, Davies SW, Bates GP. Sathasivam K, et al. Among authors: bates gp. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.

5

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH. Tabrizi SJ, et al. Ann Neurol. 2000 Jan;47(1):80-6. doi: 10.1002/1531-8249(200001)47:1<80::aid-ana13>3.3.co;2-b. Ann Neurol. 2000. PMID: 10632104

6

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.

Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Murphy KP, et al. Among authors: bates gp. J Neurosci. 2000 Jul 1;20(13):5115-23. doi: 10.1523/JNEUROSCI.20-13-05115.2000. J Neurosci. 2000. PMID: 10864968 Free PMC article.

7

Amyloid-like inclusions in Huntington's disease.

McGowan DP, van Roon-Mom W, Holloway H, Bates GP, Mangiarini L, Cooper GJ, Faull RL, Snell RG. McGowan DP, et al. Among authors: bates gp. Neuroscience. 2000;100(4):677-80. doi: 10.1016/s0306-4522(00)00391-2. Neuroscience. 2000. PMID: 11036200

8

Huntingtin aggregation and toxicity in Huntington's disease.

Bates G. Bates G. Lancet. 2003 May 10;361(9369):1642-4. doi: 10.1016/S0140-6736(03)13304-1. Lancet. 2003. PMID: 12747895 Review.

9

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.

Landles C, Bates GP. Landles C, et al. Among authors: bates gp. EMBO Rep. 2004 Oct;5(10):958-63. doi: 10.1038/sj.embor.7400250. EMBO Rep. 2004. PMID: 15459747 Free PMC article. Review.

10

Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Benn CL, Landles C, Li H, Strand AD, Woodman B, Sathasivam K, Li SH, Ghazi-Noori S, Hockly E, Faruque SM, Cha JH, Sharpe PT, Olson JM, Li XJ, Bates GP. Benn CL, et al. Among authors: bates gp. Hum Mol Genet. 2005 Oct 15;14(20):3065-78. doi: 10.1093/hmg/ddi340. Epub 2005 Sep 23. Hum Mol Genet. 2005. PMID: 16183657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page